There's just so many ways that you can get it, and it's nothing that I did to myself." Talei said she often sees theories online about her condition in the comments sections, many of which ask whether she's resorted to using glucagon-like peptide-1 receptor agonist drugs (GLP-1RAs) that have an increased risk of gastroparesis, according a May 2024 study published by the Cleveland Clinic
Phase 2 trial data (Jastreboff et al., NEJM 2023) identified nausea, vomiting, diarrhoea, and constipation as the most common GI side effects
5 Tesamorelin LiverTox (NIH/NIDDK, 2018)Clinical and research information, including formulation storage (Egrifta vs Egrifta SV) and reconstitution handling
Risk factors include smoking, chronic pancreatitis, family history, obesity, and diabetes itselfconditions that may overlap with the patient population prescribed Mounjaro
In last years KFF survey, about half the states said they were interested in covering GLP-1s for weight loss, according to Elizabeth Williams, a senior policy manager at KFF who focuses on Medicaid
Targeting myocardial substrate metabolism in heart failure: potential for new therapies
